Ignite the Africa Health Revolution

• Recap of Day 1 Ministerial discussions and industry action points.

Africa’s healthtech sector is at a turning point, with digital innovations reshaping healthcare delivery, diagnostics, and patient management. As investment in health technology gains momentum, what will it take to scale solutions and ensure equitable access? This panel will bring together industry leaders to explore the investment landscape, regulatory challenges, and the role of AI and data-driven technologies in transforming healthcare across the continent.

Key Discussion Points:

• What are the key investment opportunities in African healthtech, and how can startups attract funding and scale successfully?
• How can pharma harness AI, big data, and digital health tools to advance drug development and patient care?
• How can Africa drive healthcare innovation while ensuring data security, privacy, and ethical AI adoption?
• What strategies can expand digital health access to underserved communities, particularly in remote and low-connectivity regions?

Africa’s pharmaceutical, biotech, and research sectors are poised for rapid growth, yet unlocking their full potential requires stronger collaboration between industry players, governments, and investors. This panel will explore how strategic partnerships can drive innovation, boost local manufacturing, and accelerate R&D to meet the continent’s healthcare needs.

Key Discussion Points:

• How can African nations attract multinational pharma and biotech investment to drive technology transfer and local capacity building?
• What strategies can governments use to secure pharma investment while ensuring equitable access to affordable medicine?
• How can academic institutions and research organizations accelerate innovation and the development of treatments for Africa’s most pressing health challenges?

Non-communicable diseases (NCDs) are now Africa’s fastest-growing health crisis, responsible for nearly 40% of deaths across the continent. With cancer, cardiovascular disease, diabetes, and respiratory illnesses on the rise, healthcare systems must rapidly adapt to address this shifting burden. This panel will explore the role of public-private partnerships, technology, and sustainable financing in tackling NCDs at scale.

Key Discussion Points:

• What are the economic and healthcare consequences of Africa’s growing NCD burden, and what policy interventions are critical for long-term resilience?
• How can pharma, medtech, and digital health leaders co-create scalable solutions for NCD management, from local drug production to AI-driven diagnostics?
• What role do AI-powered early detection, precision medicine, and next-gen diagnostics play in transforming Africa’s approach to NCDs, and how can regulatory innovation accelerate adoption?

Africa’s healthcare future hinges on early detection, rapid response, and real-time disease intelligence. From pandemics to rising non-communicable diseases, visibility remains a critical challenge. This panel will explore how AI, big data, and cross-sector collaboration can revolutionize disease tracking and outbreak preparedness.

 Key Discussion Points:

• How can African governments, global health organizations, and pharma companies collaborate to build a robust disease surveillance ecosystem?
• What role do AI, genomics, and real-world data play in improving disease visibility and accelerating outbreak response?
• How can pharma and biotech companies invest in Africa’s public health efforts—spanning vaccine R&D, diagnostics, and supply chain resilience?
• What funding and policy models can support large-scale public health initiatives while ensuring long-term sustainability?

As healthcare investment in Africa grows, how can financial returns align with ethical, sustainable healthcare outcomes? This panel will explore the balance between profitability, accessibility, and impact. From pricing strategies to impact investing and regulatory frameworks, experts will discuss how to ensure healthcare investments drive both commercial success and long-term health equity.

• How can African nations attract private investment in healthcare while ensuring equitable access to essential treatments and services?
• What role should government regulation and corporate social responsibility play in shaping ethical, patient-centric healthcare investments?
• How can value-based healthcare models drive sustainable revenue for pharma while improving patient outcomes in Africa?
• What is the right balance between private sector-driven healthcare solutions and publicly funded systems in Africa’s future healthcare model?

• The commitments needed to drive long-term transformation in healthcare investment.